Colon Solid Tumor Rules

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Introduction

Note 1: New terms and codes in these rules are based on the WHO Classification of Tumors of the Digestive System 2010 edition.

Note 2: Ninety-eight percent of colon cancers are adenocarcinoma and adenocarcinoma subtypes.

Note 3: Mixed histologies and specific variants or subtypes of adenocarcinoma other than mucinous/colloid or signet ring cell are

rare. A less common combination is mixed adenoneuroendocrine carcinoma (MANEC) 8244 (previously called

adenocarcinoma and carcinoid). The new terminology was originally proposed for tumors arising from goblet cell carcinoid

but with more aggressive adenocarcinoma histology. It was also proposed because carcinoids are a subgroup of

neuroendocrine carcinoma. Pathologists may still diagnose adenocarcinoma and carcinoid, adenocarcinoid, or

adenocarcinoma and a specific neuroendocrine tumor or adenocarcinoma arising from/with a NET (including specific types

of NET-like goblet cell carcinoid). Over time, the histologic diagnoses will change to MANEC.

Note 4: De novo (previously called frank) adenocarcinoma arises in the mucosa of the bowel, not in a polyp.

Note 5: Terms Seen More Frequently: NET, NEC, GIST

• NET (neuroendocrine tumor): The term NET is gradually replacing carcinoid; however, some pathologists still use the

term carcinoid

• NEC (neuroendocrine carcinoma): The term NEC includes small cell neuroendocrine carcinoma, large cell

neuroendocrine carcinoma, and poorly differentiated neuroendocrine carcinoma

• GIST (gastrointestinal stromal tumor):

o GISTs were originally thought to be smooth muscle tumors but are now thought to originate from the interstitial

cells of Cajal, neuro-regulatory cells in the GI tract. Prior to the implementation of an ICD-O-3 histology code for

GISTs in 2001, they were reported as a GI sarcoma, usually leiomyosarcoma

o GISTs are more common in the stomach (60%) and small intestine (30%), but 1-2% occur in the colon and 3% in

the rectum

o About a quarter of gastric GISTs are malignant

o It is often difficult for the pathologist to determine the behavior of a GIST

o GIST NOS becomes a reportable neoplasm beginning with cases diagnosed 1/1/2021 forward

Note 6: Tables and rules refer to ICD-O rather than ICD-O-3. The version is not specified to allow for updates. Use the currently

approved version of ICD-O.

Note 7: 2007 MPH Rules and 2018 Solid Tumor Rules are used based on date of diagnosis.

• Tumors diagnosed 01/01/2007 through 12/31/2017: Use 2007 MPH Rules

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

• Tumors diagnosed 01/01/2018 and later: Use 2018 Solid Tumor Rules

• The original tumor diagnosed before 1/1/2018 and a subsequent tumor diagnosed 1/1/2018 or later in the same primary

site: Use the 2018 Solid Tumor Rules.

Note 8: For those sites/histologies which have recognized biomarkers, the biomarkers are most frequently used to target treatment.

Currently, there are clinical trials being conducted to determine whether these biomarkers can be used to identify multiple

primaries and/or histologic type. Follow the Multiple Primary Rules; do not code multiple primaries based on biomarkers.

Changes from 2007 MPH Rules

These changes are effective with cases diagnosed 1/1/2018 and later.

1. 2007 Rules instruct “Code the histology from the most representative specimen.” For all sites except breast and CNS, 2018 Rules

instruct “Code the most specific histology from biopsy or resection. When there is a discrepancy between the biopsy and resection

(two distinctly different histologies/different rows), code the histology from the most representative specimen (the greater amount

of tumor).”

2. Rectum and Rectosigmoid are now included with the Colon Rules. In the 2007 MPH Rules, they were included with Other Sites.

3. There are new multiple primary rules which address anastomotic recurrence.

4. Neuroendocrine tumors (formerly carcinoid) arising in the appendix are reportable for cases diagnosed 1/1/2015 and forward.

5. Rule clarification: Pseudomyxoma peritonei (accumulation of mucin-secreting tumor cells in the abdominal or pelvic cavity)

now has a two-tiered system (WHO 2010) that classifies pseudomyxoma peritonei as either high-grade or low-grade (see

below). Pseudomyxoma peritonei is usually associated with mucinous tumors of the appendix and is rarely associated with

ovarian mucinous tumors.

• High-grade pseudomyxoma peritonei is malignant /3

• Low-grade pseudomyxoma peritonei is not malignant /1

• See Histology Rules for coding instructions

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

6. There are dysplasias which have been assigned an in situ behavior code /2 in WHO and in the ICD-O Update. Despite

becoming a /2, they are not reportable in the US. They are reportable in Canada.

• Dysplasia was not collected in the past. If dysplasia is added to the database with the same code as in situ tumors, there

will be a huge upsurge in the incidence of in situ neoplasms. The various agencies are looking for solutions to this

issue.

• There would be no way to separate the dysplasias from the in-situ neoplasms in the database, which would cause

problems with surveillance (long-term studies) since the prognosis and probabilities of disease progression are different

between an in-situ tumor and a dysplasia

• Pathologists frequently use the term “severe dysplasia” or “high grade dysplasia” in place of carcinoma in situ.

Code CIS only if the pathologist expressly states “CIS”

7. Polyps are now disregarded when coding histology. For example, adenocarcinoma in an adenomatous polyp is coded as

adenocarcinoma 8140. For the purposes of determining multiple primaries, tumors coded as adenocarcinoma in a polyp for pre-

2018 cases should be treated as adenocarcinoma 8140.

New codes/terms are identified by asterisks (*) in the histology table in the Terms and Definitions.

New for 2022

1. Timing changes to rules M7 and M8: The timing for subsequent tumors at the anastomosis has changed from 24 months to 36

months. The change is effective for cases diagnosed beginning 1/1/2022 forward. For cases diagnosed 1/1/2018 through

12/31/2021, the timing rule remains at 24 months.

2. Low grade appendiceal neoplasm (LAMN) will become reportable effective for cases diagnosed 1/1/2022 forward. LAMN

may be either in situ 8480/2 or malignant 8480/3 based on physician statement of behavior. LAMN diagnosed prior to

1/1/2022 are not reportable.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Equivalent or Equal Terms

These terms can be used interchangeably:

• And; with

Note: “And” and “with” are used as synonyms when describing multiple histologies within a single tumor.

• Carcinoid; NET; neuroendocrine tumor

• Carcinoma; adenocarcinoma;

o A histology type must be stated for these terms to be equal

o Example: Mucinous carcinoma and mucinous adenocarcinoma are both coded 8480

• De novo; frank adenocarcinoma (obsolete)

• Familial polyposis; familial adenomatous polyposis (FAP) 8220

• Intramucosal; lateral extension within the mucosal layer of the GI tract

• Invasion through colon wall; extension through colon wall; transmural

Note: The term “transmural” is used to describe extension through all layers of the wall, but not past the wall OR extension through

the serosa into the mesentery. Read the pathology report carefully.

• Mucinous; mucoid; mucous; colloid

• Neuroendocrine carcinoma; NEC

• Polyp; adenoma; polyp NOS; adenomatous polyp

Note 1: The term “polyp” means projecting from a surface.

Note 2: There are many kinds of polyps. Most common are adenomas, which are part of the adenoma-cancer sequence.

Note 3: Other types of polyps include hyperplastic, juvenile, Peutz-Jeghers and serrated adenoma/polyp.

• Serosa; visceral peritoneum

• Simultaneous; existing at the same time; concurrent; prior to first course treatment

• Site; topography

• Tumor; mass; tumor mass; lesion; neoplasm

The terms tumor, mass, tumor mass, lesion, and neoplasm are

not

used in a standard manner in clinical diagnoses,

scans, or consults.

Disregard

the terms unless there is a

physician’s statement

that the term is malignant/cancer

These terms are used

ONLY

to determine multiple primaries

Do not

use these terms for casefinding or determining reportability

• Type; subtype; variant

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Terms that are NOT Equivalent or Equal

These terms are not equivalent. There are no casefinding implications.

• Carcinoma, NOS 8010 is not equivalent to adenocarcinoma, NOS 8140

• Component is not equivalent to subtype/type/variant

Note: Component is only coded when the pathologist specifies the component as a second carcinoma.

• Exophytic and polypoid are not equivalent to either an adenoma or an adenomatous polyp. The terms “exophytic” and

“polypoid” refer to anything projecting from the bowel mucosa into the lumen. The lesion may be benign, malignant, or

inflammatory.

• Phenotype is not equivalent to subtype/type/variant

• Polypoid adenocarcinoma is not equivalent to adenocarcinoma in a polyp

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Table 1: Specific Histologies, NOS, and Subtypes/Variants

Use Table 1 as directed by the Histology Rules to assign the more common histology codes for malignancies found in the colon,

rectosigmoid and rectum.

Note 1: Rare histologies may not be listed in the table. When a histology term is not found, reference ICD-O and all updates.

Note 2: Submit a question to Ask a SEER Registrar when the histology code is not found in Table 1, ICD-O or all updates.

Note 3: Behavior codes are listed when the term has only one possible behavior (either a /2 or /3). For histologies which may be

either /2 or /3, a behavior code is not listed. Code behavior from pathology.

Column 1 contains specific and NOS histology terms.

• Specific histology terms do not have subtypes/variants

• NOS histology terms do have subtypes/variants

Column 2 contains synonyms for the specific or NOS term. Synonyms have the same histology code as the specific or NOS term.

Column 3 contains subtypes/variants of the NOS histology. Subtypes/variants do not have the same histology code as the NOS

term.

Specific and NOS Term and Code

Synonyms for Specific or NOS Term

Subtypes/Variants

Adenocarcinoma 8140

Note 1: See Histology Rules

for

instructions on coding

adenocarcinoma

subtypes/variants arising in a

polyp

Note 2: When the term intestinal

adenocarcinoma is used to

describe a colon primary, it

simply means the appearance is

Adenocarcinoma, NOS

Adenocarcinoma/carcinoma in a polyp

NOS

(now coded to 8140)

Adenocarcinoma/carcinoma in adenomatous

polyp (now coded to 8140)

Adenocarcinoma/carcinoma in polypoid

adenoma (now coded to 8140)

Adenocarcinoma/carcinoma in serrated

adenoma (now coded to 8140)

Adenocarcinoma and mucinous carcinoma,

mucinous documented as less than 50% of

tumor OR percentage of mucinous

Adenoid cystic carcinoma 8200

Cribriform comedo-type carcinoma/

adenocarcinoma, cribriform comedo-type

8201*

Diffuse adenocarcinoma/carcinoma 8145

High grade appendiceal mucinous neoplasm

(HAMN)/Low grade appendiceal mucinous

neoplasm 8480- see Note 3

Linitis plastica 8142/3Medullary

adenocarcinoma/carcinoma 8510

Micropapillary carcinoma 8265*

Mucinous/colloid adenocarcinoma/carcinoma

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Specific and NOS Term and Code

Synonyms for Specific or NOS Term

Subtypes/Variants

similar to adenocarcinoma seen in

the stomach and is coded to

adenocarcinoma NOS 8140

Note 3:Effective 1/1/2022, LAMN

becomes reportable and is coded

8480/2, unless the pathologist

indicates invasive behavior, which

is coded 8480/3. HAMN can be

either /2 or /3 depending on the

pathologist statement of behavior.

unknown/not documented

Adenocarcinoma and signet ring cell carcinoma,

percentage of signet ring cell carcinoma

documented as less than 50% of tumor OR

unknown/not documented

Adenocarcinoma/carcinoma in tubular polyp

(now coded to 8140)

Adenocarcinoma/carcinoma in tubulovillous

polyp (now coded to 8140)

Adenocarcinoma/carcinoma in villous adenoma

(now coded to 8140)

Adenocarcinoma in any type of polyp

Adenocarcinoma, intestinal type

Adenocarcinoma and cribriform carcinoma

percentage of cribriform documented as less

than 50% of tumor OR unknown/not

documented

Adenocarcinoma with mucinous and signet

ring cell features

Comedocarcinoma

Intestinal adenocarcinoma

8480

Mucoepidermoid carcinoma 8430

Serrated adenocarcinoma 8213*

Signet ring cell/poorly cohesive

adenocarcinoma/carcinoma 8490

Superficial spreading adenocarcinoma 8143

Tubulopapillary carcinoma 8263

Undifferentiated adenocarcinoma/carcinoma

8020

Adenosquamous carcinoma 8560

Note: This code cannot be used for

adenocarcinoma subtypes/variants with

squamous cell/epidermoid carcinoma

Mixed adenocarcinoma NOS and epidermoid

carcinoma

Mixed adenocarcinoma NOS and squamous cell

carcinoma

Combined small cell carcinoma 8045

Small cell carcinoma mixed with

• Adenocarcinoma OR

• Neuroendocrine carcinoma OR

• Any other type of carcinoma/adenocarcinoma

Gastrinoma 8153

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Specific and NOS Term and Code

Synonyms for Specific or NOS Term

Subtypes/Variants

Gastrointestinal stromal tumor 8936/3

Note: See standard setter reportability

guidelines.

Gastrointestinal stromal tumor

GIST, NOS

GIST, malignant

Gastrointestinal stromal sarcoma

Mixed adenoneuroendocrine

carcinoma 8244

Adenocarcinoma ex-goblet cell

Adenocarcinoma mixed with high-grade large

cell neuroendocrine carcinoma

Adenocarcinoma mixed with high-grade small

cell neuroendocrine carcinoma

MANEC

Goblet cell adenocarcinoma/Goblet cell

carcinoid 8243

Neuroendocrine carcinoma 8246

NEC

Large cell NEC 8013

Small cell NEC 8041

Neuroendocrine tumor Grade 1 (G1)

8240

Note: When the diagnosis is exactly

“carcinoid” it may be a Grade 1 or

Grade 2 NET. Default is coding

NET Grade 1 8240.

Carcinoid NOS

Low-grade neuroendocrine tumor

NET Grade 1 (G1)

Well differentiated neuroendocrine tumor

EC cell serotonin-producing

NET/enterochromaffin cell carcinoid 8241

Neuroendocrine tumor (NET) Grade 2 (G2) 8249

Somatostatin-producing NET 8156

Sarcoma NOS 8800/3

Angiosarcoma/hemangiosarcoma 9120/3

Leiomyosarcoma 8890/3

Spindle cell carcinoma 8032

Squamous cell carcinoma 8070

Epidermoid carcinoma NOS

Squamous cell carcinoma NOS

Squamous cell epithelioma

*These new codes were approved by the IARC/WHO Committee for ICD-O.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Table 2: Histologies Not Reportable for Colon, Rectosigmoid and Rectum

Column 1 lists the non-reportable histology term and code for NOS or specific

Column 2 lists the synonym(s) for the term

Column 3 lists the subtype/variant of the NOS term with the histology code

Column 4 lists the reason these histologies are not reportable

Specific or NOS Term and

Code

Synonyms

Subtype/Variant of NOS

with Histology Code

Reason not reportable

Adenoma 8140/0

Note: No malignancy in

polyps

Adenoma NOS

Tubular adenoma 8211/0

Tubulovillous adenoma 8263/0

Villous adenoma 8261/0

Non-malignant

Adenomatous polyp, high

grade dysplasia 8210/2

Non-reportable terminology

Cowden-associated polyp No

code

Note: No malignancy in

polyps

Cowden disease

Cowden syndrome

Multiple hamartoma syndrome

Non-malignant /no code

Dysplasia, high grade 8148/2

Note: Colorectal primaries

only (C180-C189, C199

and C209)

High-grade dysplasia

Intraepithelial neoplasia, high

grade

CURRENTLY NOT REPORTABLE

Dysplasia, low grade 8148/0*

Note: Colorectal primaries

only (C180-C189, C199

and C209)

Intraepithelial neoplasia, low

grade

Non-malignant

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Specific or NOS Term and

Code

Synonyms

Subtype/Variant of NOS

with Histology Code

Reason not reportable

Familial adenomatous

polyposis (FAP) No code

Adenomatous polyposis coli

Bussey-Garder polyposis

Familial multiple polyposis

Familiar polyposis coli

Familial polyposis of the colon

and rectum

Familial polyposis of the

gastrointestinal tract

Gardner syndrome

Multiple adenomatosis

Reportable only when there is cancer in a

polyp

Gangliocytic paraganglioma

8683/0

Non-malignant

Gastrointestinal stromal

tumor stated as benign,

borderline, or non-malignant

8936/1 (SEE NOTE in

column 2)

GIST NOS

GIST, behavior not specified

Note: Gastrointestinal stromal

tumor, NOS is not reportable for

cases diagnosed prior to

1/1/2021. Cases diagnosed

1/1/2021 forward are reportable

Non-malignant

Hyperplastic polyp No code

Non-malignant/no code

Inflammatory or

pseudopolyp No code

Reactive lesions; mimic carcinoma

Intestinal-type adenoma,

high grade 8144/2

Non-reportable terminology

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Specific or NOS Term and

Code

Synonyms

Subtype/Variant of NOS

with Histology Code

Reason not reportable

Juvenile polyp No code

Combined juvenile

polyposis/hereditary

Hemorrhagic telangietasis

(Osler-Webec-Rendu) syndrome

Familial juvenile polyposis

Generalized juvenile polyposis

Hamartomatous gastrointestinal

polyposis;

Juvenile polyposis

Juvenile polyposis coli

Juvenile polyposis of infancy

Non-malignant / no code

L cell glucagon-like peptide

and PP/PYY-producing

NETs 8152/1*

Non-malignant

Leiomyoma 8890/0

Non-malignant

Lipoma 8850/0

Benign accumulation of fat cells that are

circumscribed or encapsulated

Low-grade appendiceal

mucinous neoplasm 8480/1

Note: May have low-grade,

non-invasive

pseudomyxoma

peritonei, mucinous

implants in peritoneum

or beyond

LAMN

Non-malignant

Note: LAMN is non-reportable for cases

diagnosed prior to 1/1/2022. Beginning

1/1/2022, LAMN becomes a reportable

neoplasm- See Table 1

Lynch syndrome No code

Non-malignant/no code

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Specific or NOS Term and

Code

Synonyms

Subtype/Variant of NOS

with Histology Code

Reason not reportable

Mesenchymal tumors

Granular cell tumor 9580/0

Hemangioma 9120/0

Non-malignant

Peutz-Jeghers polyp No code

Intraepithelial neoplasia in

Peutz-Jeghers polyp(s)

Periorificial lentiginosis

Peutz-Jeghers polyposis

Polyps-and-spots syndrome

Non-malignant/no code

Pseudomyxoma peritonei

(when pathologist does not

designate as malignant OR

implants are benign) 8480/1

Non-malignant. When both implants and

site of origin are benign, the case is not

reportable.

Serrated dysplasia, high

grade 8213/2

Non-reportable terminology

Sessile serrated

adenoma/polyp 8213/0*

Note: No malignancy in

polyps

Serrated polyposis

Sporadic serrated polyps

Traditional serrated adenoma

Non-malignant

Tubular adenoma, high

grade 8211/2

Non-reportable terminology

Tubular carcinoid, no

malignancy 8245/1

Non-malignant

Tubulovillous adenoma, high

grade 8263/2

Non-reportable terminology

Villous adenoma, high grade

8261/2

Non-reportable terminology

*These new codes were approved by the IARC/WHO Committee for ICD-O

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Illustrations

Colonoscopy measurements which may be used to determine primary site when no site is designated

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

GI System

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Polyps and de novo or “frank” adenocarcinoma in colon

Source: http://upload.wikimedia.org/wikipedia/commons/4/44/Colon_cancer.jpg

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Large intestine; snare instrument to remove polyps

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Colon Surgery: Hemicolectomy

The primary treatment for colon cancer is surgery. Part of the large bowel and the surrounding lymph nodes are removed. The

remaining bowel is then joined together (anastomosis).

http://www.cedars-sinai.edu/Patients/Programs-and-Services/Colorectal-Cancer-Center/Services-and-Treatments/Rectal-Cancer.aspx

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Rectal Surgery

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Equivalent Terms and Definitions

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Multiple Primary Rules

Jump to Histology Coding Rules

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Note 1: These rules are NOT used for tumor(s) described as metastases. Metastatic tumors include but are not limited to:

• Discontinuous lesions in soft tissue adjacent to

primary site

• Regional or distant lymph nodes for the

primary site being abstracted as identified in

Summary Staging Manual

• Brain

• Liver

• Lung

• Peritoneum

• Spinal cord (not frequent)

Note 2: 2007 MPH Rules and 2018 Solid Tumor Rules are used based on date of diagnosis.

• Tumors diagnosed 01/01/2007 through 12/31/2017: Use 2007 MPH Rules

• Tumors diagnosed 01/01/2018 and later: Use 2018 Solid Tumor Rules

• The original tumor diagnosed before 1/1/2018 and a subsequent tumor diagnosed 1/1/2018 or later in the same

primary site: Use the 2018 Solid Tumor Rules

Unknown if Single or Multiple Tumors

Note: Collision tumors are counted as two individual tumors for the purpose of determining multiple primaries. Collision tumors

were originally two separate tumors that arose in close proximity. As the tumors increased in size, they merged or overlapped

each other. Use the Multiple Tumors module.

Rule M1 Abstract a single primary

when it is not possible to determine if there is a single tumor or multiple tumors.

Note 1: Use this rule only after all information sources have been exhausted.

Note 2: Examples of cases with minimal information include

• Death certificate only (DCO)

• Cases for which information is limited to pathology report only

ο Outpatient biopsy with no follow-up information available

ο Multiple pathology reports which do not specify whether a single tumor or multiple tumors have been biopsied

and/or resected

This is the end of instructions for Unknown if Single or Multiple Tumors

Prepare one abstract. Use the histology rules to assign the appropriate histology code.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Single Tumor

Note: Collision tumors are counted as two individual tumors for the purpose of determining multiple primaries. Collision tumors

were originally two separate tumors that arose in close proximity. As the tumors increased in size, they merged or overlapped

each other. Use the Multiple Tumors module.

Rule M2 Abstract a single primary

when there is a single tumor.

Note 1: A single tumor is always a single primary.

Note 2: The tumor may overlap onto or extend into adjacent/contiguous site or subsites.

Note 3: The tumor may have in situ and invasive components.

Note 4: The tumor may have two or more histologic components.

This is the end of instructions for Single Tumor

Prepare one abstract. Use the histology rules to assign the appropriate histology code.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Multiple Tumors

Note 1: Multiple tumors may be a single primary or multiple primaries.

Note 2: Collision tumors are counted as two individual tumors for the purpose of determining multiple primaries. Collision tumors

were originally two separate tumors that arose in close proximity. As the tumors increased in size, they merged or overlapped

each other. Use the Multiple Tumors module to determine if they are a single primary or multiple primaries.

Rule M3 Abstract a single primary

when there is adenocarcinoma in situ and/or invasive in at least one polyp AND

• There is a clinical diagnosis of familial polyposis (FAP) OR

• Greater than 100 polyps are documented (no diagnosis of FAP)

Note 1: A diagnosis of familial polyposis (FAP) is made when the patient has greater than 100 adenomatous polyps. Polyps with

adenocarcinoma and benign polyps will be present. Because there are many polyps, the pathologist does not examine every

polyp.

Note 2: In situ /2 and malignant /3 adenocarcinoma in polyps, malignancies with remnants of a polyp, as well as de novo

(previously called frank) malignancies may be present in multiple segments of the colon or in both the colon and rectum.

Polyposis may be present in other GI sites such as stomach (a de novo does not have to be present; all adenocarcinoma

may be in polyps).

Note 3: FAP is a genetic disease. The characteristics of FAP are numerous precancerous polyps in the colon and rectum when

the patient reaches puberty. If not treated, the polyps typically become malignant. Patients often have total colectomies.

Note 4: Multiple polyps in the colorectum is not equivalent to FAP.

Note 5: Code primary site as follows:

• Present in more than one segment of colon: C189 colon, NOS

• Present in colon and rectosigmoid OR colon and rectum: C199 rectosigmoid junction

• Present in colon and small intestine: C260 intestinal tract, NOS (there is no code for large and small bowel)

Note: In addition to the colon and small intestine, FAP may also be present in the:

• Stomach AND/OR

• Rectosigmoid AND/OR

• Rectum

Example: The patient has a diagnosis of FAP. The operative report and physician’s documentation say that polyps with

adenocarcinoma were present in specimens removed from the ascending colon and the sigmoid colon. The

ascending and sigmoid colon are part of the large bowel. Code the primary site C189 colon NOS.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Rule M4 Abstract multiple primaries

when there are separate, non-contiguous tumors in sites with ICD-O site codes that differ

at the second CXxx and/or third CxXx character.

Note 1: Definition of separate/non-contiguous tumors: at least two malignancies which do not overlap/merge.

Note 2: Differences at either the second or third characters are different primary sites/multiple primaries.

Example 1: Breast C50x and colon C18x

Example 2: Colon C18x and rectum C209 (This does not include FAP- see earlier rules)

Note: This rule does not apply to a single overlapping malignancy of colon and rectum.

Rule M5 Abstract multiple primaries

when separate/non-contiguous tumors are two or more different subtypes/variants in

Column 3, Table 1 in the Equivalent Terms and Definitions. Timing is irrelevant.

Note: The tumors may be subtypes/variants of the same or different NOS histologies.

• Same NOS: Medullary carcinoma NOS 8510/3 and tubulopapillary adenocarcinoma 8263/3 are both subtypes of

adenocarcinoma NOS 8140/3 but are distinctly different histologies. Abstract multiple primaries.

• Different NOS: Goblet cell carcinoid 8243/3 is a subtype of mixed adenoneuroendocrine carcinoma 8244/3;

somatostatin-producing NET 8156/3 is a subtype of neuroendocrine tumor Grade 1 (G1) 8240/3. They are distinctly

different histologies. Abstract multiple primaries.

Rule M6 Abstract multiple primaries

when separate/non-contiguous tumors are on different rows in Table 1 in the Equivalent

Terms and Definitions. Timing is irrelevant.

Note: Each row in the table is a distinctly different histology.

Rule M7 Abstract multiple primaries

when a subsequent tumor arises at the anastomotic site AND:

• One tumor is a NOS and the other is a subtype/variant of that NOS OR

• The subsequent tumor occurs greater than 36 months after original tumor resection OR

Note: For cases diagnosed prior to 1/1/2022, the time interval is greater than 24 months.

• The subsequent tumor arises in the mucosa (see illustration)

Note: Bullet three does not apply to GIST. GISTs only start in the wall; never in the mucosa.

Example: (For bullet 1: NOS and subtype/variant) The original tumor was adenocarcinoma NOS 8140. The patient had a

hemicolectomy. There was a recurrence at the anastomotic site diagnosed exactly as mucinous adenocarcinoma 8480.

Mucinous adenocarcinoma is a subtype/variant of the NOS adenocarcinoma, but they are two different histologies. Code

two primaries, one for the original adenocarcinoma NOS and another for the subsequent anastomotic site mucinous

adenocarcinoma.

Note 1: There may or may not be physician documentation of anastomotic recurrence. Follow the rules.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Note 2: When the original tumor was diagnosed prior to 1/1/2018 and was coded to adenocarcinoma in a polyp, and the

anastomotic site tumor is adenocarcinoma per 2018 rules, the tumors are the same histology. ICD-O codes differ because

of changes in histology coding rules.

Note 3: The tumor may or may not invade into the colon wall or adjacent tissue.

Note 4: A “rectal stump” is an anastomotic site.

Note 5: These rules are hierarchical. Only use this rule when previous rules do not apply.

Rule M8 Abstract a single primary

when a subsequent tumor arises at the anastomotic site AND:

• The subsequent tumor occurs less than or equal to 36 months after original tumor resection OR

Note: For cases diagnosed prior to 1/1/2022, timing is less than or equal to 24 months

• The tumor arises in colon/rectal wall and/or surrounding tissue; there is no involvement of the mucosa (see

illustration) OR

• The pathologist or clinician documents an anastomotic recurrence

Note 1: Bullet two does not apply to GIST. GISTs only start in the wall; never in the mucosa.

Note 2: The physician may stage the subsequent tumor because the depth of invasion determines the second course of treatment.

Note 3: These tumors are a single primary/recurrence. Registrars that collect recurrence information should record the

information in the recurrence fields.

Note 4: A “rectal stump” is an anastomotic site.

Rule M9 Abstract multiple primaries

when there are separate, non-contiguous tumors in sites with ICD-O site codes that differ

at the fourth characters C18X.

Note: Differences at the fourth character include different segments of the colon. Abstract a primary for each separate non-

contiguous tumor in a different segment of the colon. This rule is not used for colon NOS C189. C189 is rarely used other

than DCO.

Example: The patient has adenocarcinoma in situ in a sigmoid polyp and mucinous adenocarcinoma in a polyp in the descending

colon, the site code differs at the fourth character (sigmoid C187 and descending C186). Code two primaries, one for

the sigmoid and another for the descending colon.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Rule M10 Abstract multiple primaries

when the patient has a subsequent tumor after being clinically disease-free for greater

than one year after the original diagnosis or last recurrence.

Note 1: Clinically disease-free means that there was no evidence of recurrence on follow-up.

• Colonoscopies are NED

• Scans are NED

Note 2: When there is a recurrence less than or equal to one year of diagnosis, the “clock” starts over. The time interval is

calculated from the date of last recurrence. In other words, the patient must have been disease-free for greater than one

year from the date of the last recurrence.

Note 3: When the first course of treatment was a polypectomy only, this rule means there were no recurrences for greater than

one year.

Note 4: When the first course of treatment was a colectomy or A&P resection, there were no anastomotic recurrences for

greater than one year.

Note 5: When it is unknown/not documented whether the patient had a recurrence, default to date of diagnosis to compute the

time interval.

Note 6: The physician may state this is a recurrence, meaning the patient had a previous colon tumor and now has another colon

tumor. Follow the rules; do not attempt to interpret the physician’s statement.

Rule M11 Abstract a single primary

when synchronous, separate/non-contiguous tumors are on the same row in Table 1 in the

Equivalent Terms and Definitions.

Note: The same row means the tumors are:

• The same histology (same four-digit ICD-O code) OR

• One is the preferred term (column 1) and the other is a synonym for the preferred term (column 2) OR

• A NOS (column 1/column 2) and the other is a subtype/variant of that NOS (column 3)

Rule M12 Abstract a single primary

(the invasive) when an in situ tumor is diagnosed after an invasive tumor.

Note 1: The rules are hierarchical. Only use this rule when none of the previous rules apply.

Note 2: The tumors may be a NOS and a subtype/variant of that NOS. See Table 1

in the Equivalent Terms and Definitions for

listings of NOS and subtype/variants.

Note 3: The in situ is recorded as a recurrence for those registrars who collect recurrence data.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Multiple Primary Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Histology Coding Rules

Rule M13 Abstract a single primary

(the invasive) when an invasive tumor is diagnosed less than or equal to 60 days after an in

situ tumor.

Note 1: The rules are hierarchical. Only use this rule when previous rules do not apply.

Note 2: Change behavior code on original abstract from /2 to /3. Do not change date of diagnosis.

Note 3: If the case has already been submitted to the central registry, report all changes.

Note 4: The physician may stage both tumors because staging and determining multiple primaries are done for different reasons.

Staging determines which treatment would be most effective. Determining multiple primaries is done to stabilize the data

for the study of epidemiology (long-term studies done on incidence, mortality, and causation of a disease with the goal of

reducing or eliminating that disease).

Note 5: See the COC and SEER manuals for instructions on coding data items such as Date of Diagnosis, Accession Year and

Sequence Number.

Rule M14 Abstract multiple primaries

when an invasive tumor occurs more than 60 days after an in situ tumor.

Note 1: Abstract both the invasive and in situ tumors.

Note 2: Abstract as multiple primaries even if physician states the invasive tumor is disease recurrence or progression.

This rule is based on long-term epidemiologic studies of recurrence intervals. The specialty medical experts (SMEs)

reviewed and approved these rules. Many of the SMEs were authors, co-authors, or editors of the AJCC Staging Manual.

Rule M15 Abstract a single primary

when tumors do not meet any of the above criteria.

Note: Use caution when applying this default rule. Please confirm that you have not overlooked an applicable rule.

Example: The pathology states adenocarcinoma in situ 8140/2 and a second non-contiguous invasive adenocarcinoma 8140/3 in the

sigmoid colon C187. Multiple tumors that are the same histology in the same primary site (same four characters of ICD-

O topography code) are a single primary.

This is the end of instructions for Multiple Tumors.

Prepare one abstract. Use the histology rules to assign the appropriate histology code. For registries collecting recurrence data: When a

subsequent tumor is “single primary,” record that subsequent tumor as a recurrence.

Prepare two or more abstracts. Use the histology rules to assign the appropriate histology code to each case abstracted.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

Priority Order for Using Documentation to Identify Histology

IMPORTANT NOTES

1. Code the histology diagnosed prior to neoadjuvant treatment.

Note 1: Histology changes may occur following immunotherapy, chemotherapy, targeted therapy, and radiation therapy.

Note 2: Neoadjuvant treatment is any tumor-related treatment given prior to surgical removal of the malignancy.

Exception: If the initial diagnosis is based on histology from FNA, smears, cytology, or from a regional or metastatic site, and

neoadjuvant treatment is given and followed by resection of primary site which identifies a different or specific histology, code the

histology from the primary site.

2. Code the histology using the following priority list and the Histology Rules. Do not change histology in order to make the case

applicable to staging.

The priority list is used for single primaries (including multiple tumors abstracted as a single primary).

This is a hierarchical list of source documentation.

Code the most specific pathology/tissue from either resection or biopsy.

Note 1: The term “most specific” usually refers to a subtype/variant.

Note 2: The histology rules instruct to code the invasive histology when there are in situ and invasive components in a single tumor.

Note 3: When there is a discrepancy between the biopsy and resection (two distinctly different histologies/different rows), code the histology

from the most representative specimen (the greater amount of tumor).

1. Tissue or pathology report from primary site (in priority order)

A. Addendum(s) and/or comment(s)

B. Final diagnosis / synoptic report as required by CAP

C. CAP protocol

Note 1: Addendums and comments on the pathology report are given a high priority because they often contain information about molecular

testing, genetic testing, and/or special stains which give a more specific diagnosis.

Note 2: The pathologist’s diagnosis from the pathology report is always reliable, so the final diagnosis is the second priority.

Note 3: The CAP protocol is a checklist which:

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

• Provides guidelines for collecting the essential data elements for complete reporting of malignant tumors and optimal patient

care

• Allows physicians to check multiple histologies

2. Tissue/pathology from a metastatic site

Note 1: Code the behavior /3.

Note 2: The tissue from a metastatic site often shows variations from the primary tumor. When it is the only tissue available, it is more

accurate than a scan.

3. Scan: The following list is in priority order.

A. CT

B. PET

C. MRI

4. Code the histology documented by the physician when none of the above are available. Use the documentation in the following

priority order:

A. Treatment plan

B. Documentation from Tumor Board

C. Documentation in the medical record that refers to original pathology, cytology, or scan(s)

D. Physician’s reference to type of cancer (histology) in the medical record

Note 1: Code the specific histology when documented.

Note 2: Code the histology to 8000 (cancer/malignant neoplasm, NOS) or as stated by the physician when nothing more specific is

documented.

5. Cytology (seldom used for colon, rectosigmoid and rectum)

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

Coding Histology

Note 1: The priority is to code the most specific histology. DO NOT USE BREAST HISTOLOGY CODING RULES FOR THIS

SITE.

Note 2: Only use this section for one or more histologies within a single tumor.

Note 3: Do not use this section in place of the Histology Rules.

1. Code the most specific histology or subtype/type/variant, regardless of whether it is described as:

A. The majority or predominant part of tumor

B. The minority of tumor

C. A component

Note 1: Mucinous and signet ring cell carcinoma must meet a percentage requirement in order to be coded. Refer to the Histology Rules if

mucinous and/or signet ring cell carcinoma is present.

Note 2: The terms above (A, B, C) must describe a carcinoma or sarcoma in order to code a histology described by those terms.

Example: When the diagnosis is adenocarcinoma with a component of medullary carcinoma, code medullary carcinoma 8510.

Negative Example: When the diagnosis is simply adenocarcinoma with a medullary component, code adenocarcinoma NOS 8140.

Do not assume this is a medullary carcinoma. This could be medullary differentiation or features.

Note 3: When the most specific histology is described as differentiation or features, see #2.

Example 1: Diagnosis for a single tumor is adenocarcinoma 8140 with the majority or predominant part of tumor being medullary

adenocarcinoma 8510. Code the subtype/variant: medullary adenocarcinoma 8510.

Example 2: Diagnosis for a single tumor is mixed neuroendocrine carcinoma 8244 with minority of tumor being goblet cell carcinoid 8243.

Code the subtype/variant: goblet cell carcinoid 8243.

Example 3: Diagnosis for a single tumor is sarcoma NOS 8800/3 with a component of leiomyosarcoma 8890/3. Code the subtype/variant:

leiomyosarcoma 8890/3.

2. Code the histology described as differentiation or features/features of ONLY when there is a specific ICD-O code for the “NOS

with ____ features” or “NOS with ____ differentiation”.

Note: Do not code differentiation or features when there is no specific ICD-O code.

3. Code the specific histology described by ambiguous terminology (list follows) ONLY when A or B is true:

A. The only diagnosis available is one histology term described by ambiguous terminology

• CoC and SEER require reporting of cases diagnosed only by ambiguous terminology

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

• Case is accessioned (added to your database) based on ambiguous terminology and no other histology information is

available/documented

Example: Outpatient biopsy says probably malignant GIST. The case is accessioned (entered into the database) as required by

both SEER and COC. No further information is available. Code the histology malignant GIST. The case meets the

criteria in #3A.

B. There is a NOS histology and a more specific (subtype/variant) described by ambiguous terminology

• Specific histology is clinically confirmed by a physician (attending, pathologist, oncologist, etc.) OR

• Patient is receiving treatment based on the specific histology described by ambiguous term

Example 1: The pathology diagnosis is adenocarcinoma consistent with micropapillary carcinoma. The oncology consult

says the patient has micropapillary carcinoma of the cecum. This is clinical confirmation of the diagnosis, code

micropapillary carcinoma. The case meets the criteria in bullet 1.

Example 2: The pathology diagnosis is mixed neuroendocrine carcinoma consistent with goblet cell carcinoid. The treatment

plan says the patient will receive the following treatment for goblet cell carcinoid. Treatment plan confirms

goblet cell carcinoid; code goblet cell carcinoid. The case meets the criteria in bullet 2.

If the specific histology does not meet the criteria in #3B, then code the NOS histology.

List of Ambiguous Terminology

Apparently

Appears

Comparable with

Compatible with

Consistent with

Favor(s)

Malignant appearing

Most likely

Presumed

Probable

Suspect(ed)

Suspicious (for)

Typical (of)

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

4. Do not code histology when described as:

• Architecture

• Foci; focus; focal

• Pattern

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

Single Tumor

Rule H1 Code adenocarcinoma with neuroendocrine differentiation 8574 when the final diagnosis is exactly “adenocarcinoma

with neuroendocrine differentiation”.

Note: Do not use this code when:

• The diagnosis is any subtype/variant of adenocarcinoma with neuroendocrine differentiation

• Any modifier other than differentiation is used, i.e., adenocarcinoma with neuroendocrine features

Rule H2 Code the histology and ignore the polyp when a carcinoma originates in a polyp.

Note 1: This is a change from the 2007 MPH rules which instructed registrars to use the codes for malignancies in a polyp, such as

adenocarcinoma in a polyp 8210.

Note 2: Sufficient data has been collected to:

• Determine the frequency with which carcinomas arise within polyps

• Establish patient care guidelines for individuals with colon polyps

Example: Colonoscopy with polypectomy finds mucinous adenocarcinoma in the polyp. Code mucinous adenocarcinoma 8480.

Rule H3 Code combined small cell carcinoma 8045 when the final diagnosis is small cell carcinoma AND any other carcinoma.

Examples:

• Small cell carcinoma 8041 and adenocarcinoma 8140

• Small cell carcinoma 8041 and neuroendocrine carcinoma 8246

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

Rule H4 Code mixed mucinous and signet ring cell as follows:

• Adenocarcinoma with mucinous and signet ring features – code adenocarcinoma 8140

• Mucinous carcinoma and signet ring cell carcinoma:

ο Mucinous carcinoma documented as greater than 50% – code mucinous carcinoma 8480

ο Signet ring cell carcinoma documented as greater than 50% – code signet ring cell carcinoma 8490

ο Percentage of mucinous carcinoma and signet ring cell carcinoma unknown/not designated- code

adenocarcinoma mixed subtypes 8255

Note: This rule is for mucinous carcinoma and signet ring cell carcinoma in a single tumor. For mucinous

adenocarcinoma mixed with another histology OR signet ring cell carcinoma mixed with another histology,

proceed through the rules.

Rule H5 Code low grade appendiceal mucinous neoplasm (LAMN) and high grade appendiceal mucinous neoplasm

(HAMN) 8480/2 when:

• Diagnosis date is 1/1/2022 forward AND

• Behavior is stated to be in situ/non-invasive OR

• Behavior is not indicated

Note 1: ICD-O-3.2 lists LAMN with behavior of /1. WHO 5

Ed Digestive Systems Tumors indicates this neoplasm is considered

in situ. After consulting with WHO Digestive System editors, College of American pathologists, and AJCC GI chapter

experts, the standard setting organizations have agreed LAMN should be collected and should be assigned a behavior code

of /2 beginning with cases diagnosed 1/1/2022 forward.

Note 2: A diagnosis of LAMN or HAMN does not require the tumor be comprised of greater than 50% mucinous in order to be

coded 8480.

Note 3: If the pathologist indicates LAMN or HAMN is invasive or has a malignant behavior, continue through the rules.

Rule H6 Code invasive mucinous adenocarcinoma 8480 when the diagnosis is any of the following:

• Exactly “mucinous adenocarcinoma” (no modifiers)

• High grade appendiceal mucinous neoplasm (HAMN) stated to be invasive (DX 1/1/2022 forward)

• High-grade pseudomyxoma peritonei

• Invasive pseudomyxoma peritonei

• Low grade appendiceal mucinous neoplasm (LAMN) stated to be invasive (DX 1/1/2022 forward)

• Malignant pseudomyxoma peritonei

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

• Two histologies and mucinous is documented to be greater than 50% of the tumor

ο Mucinous carcinoma must meet a percentage requirement in order to be coded. Do not use majority of tumor,

predominantly, or predominant part of the tumor to code mucinous 8480.

Note 1: Be very careful when determining primary site; almost all pseudomyxoma peritonei originate in the appendix C181.

However, it can be metastatic disease from sites such as bowel, ovary, or bladder. Code the primary site as designated by

a physician. When the primary site is not designated, code unknown primary C809 and the histology as mucinous

carcinoma 8480.

Note 2: Report the appendiceal mucinous neoplasm as malignant /3 using the ICD-O matrix principle and the SEER and COC

Manuals when the pathology from the appendix is low-grade mucinous neoplasm (not reportable prior to 1/1/2022) AND

• The pseudomyxoma peritonei are high-grade/invasive/malignant OR

• Patient is treated for malignant pseudomyxoma peritonei OR

• The diagnosis is low grade appendiceal mucinous neoplasm (LAMN) and the physician states it is malignant OR

• The diagnosis is high grade appendiceal mucinous neoplasm (HAMN) and the physician states it is

malignant

Note 3: The following are non-reportable for cases diagnosed prior to 1/1/2022:

• Appendiceal neoplasm with low-grade pseudomyxoma peritonei AND no treatment

• No designation of high- or low-grade for the appendiceal neoplasm AND no treatment for the pseudomyxoma

peritonei

Rule H7 Code invasive signet ring cell adenocarcinoma 8490 when the diagnosis is any of the following:

• Exactly signet ring cell carcinoma (no modifiers)

• Adenocarcinoma and signet ring cell carcinoma, where signet ring cell is documented to be greater than 50% of

the tumor

ο Signet ring cell adenocarcinoma must meet a percentage requirement in order to be coded. Do not use majority of

tumor, predominantly, or predominant part of tumor to code signet ring cell 8490.

Rule H8 Code adenocarcinoma NOS 8140 when the final diagnosis is:

• Two histologies:

ο Adenocarcinoma and mucinous carcinoma

• Percentage of mucinous unknown/not documented

• Mucinous documented as less than or equal to 50% of tumor

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

ο Adenocarcinoma and signet ring cell carcinoma

• Percentage of signet ring unknown/not documented

• Signet ring cell documented as less than or equal to 50% of tumor

• Exactly adenocarcinoma OR

• Intestinal type adenocarcinoma OR adenocarcinoma intestinal type (no modifiers or additional histologic terms).

Note 1: Code 8140 adenocarcinoma NOS even if pathology says intestinal type adenocarcinoma.

Note 2: Do not use code 8144 adenocarcinoma intestinal type for colorectal primaries. Intestinal type adenocarcinoma 8144 is

used for tumors which occur in the stomach, head and neck, and specific GYN sites. It is called intestinal because it

resembles carcinoma which occurs in the colon, rectosigmoid or rectum.

Note 3: When a diagnosis of intestinal type adenocarcinoma is further described by a specific term (such as mucinous

intestinal type adenocarcinoma or signet ring cell intestinal type adenocarcinoma), it would be treated as an

adenocarcinoma with a subtype/variant.

Rule H9 Code the histology when only one histology is present.

Note 1: Use Table 1 to code histology. New codes, terms, and synonyms are included in Table 1 and coding errors may occur if

the table is not used.

Note 2: Use the ICD-O and all updates when the histology is not listed in Table 1.

Note 3: Submit a question to Ask a SEER Registrar

when the histology code is not found in Table 1, ICD-O or all updates.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

Rule H10 Code the invasive histology when in situ and invasive histologies are present in the same tumor.

Rule H11 Code the subtype/variant when there is a NOS and a single subtype/variant of that NOS such as the following:

• Adenocarcinoma 8140 and a subtype/variant of adenocarcinoma

• Mixed adenoneuroendocrine carcinoma 8244 and a subtype/variant of mixed adenoneuroendocrine carcinoma

• Neuroendocrine carcinoma 8246 and a subtype/variant of neuroendocrine carcinoma

• Neuroendocrine tumor Grade 1 (G1) 8240 and a subtype/variant of neuroendocrine tumor Grade 1 (G1)

• Sarcoma 8800 and a subtype/variant of sarcoma

Note 1: See Table 1 in the Equivalent Terms and Definitions to find NOS and subtypes/variants.

Note 2: Only code subtypes/variant when pathology gives an exact diagnosis. Do not code the subtype/variant when modified by

terms such as differentiation, features of, etc., unless there is a specific code for the histology term with the modifier.

This is the end of instructions for Single Tumor.

Code the histology using the rule that fits the case.

Multiple Tumors Abstracted as a Single Primary

Note: Multiple tumors must be a single primary to use this module. See the Multiple Primary Rules

to determine whether these tumors are a

single primary.

Rule H12 Code adenocarcinoma in familial adenomatous polyposis coli (FAP) 8220 when clinical history says the patient has

familial polyposis AND

• The final diagnosis on the pathology report from resection is adenocarcinoma in FAP OR

• There are greater than 100 polyps identified in the resected specimen

Note 1: Use this rule only when there are multiple polyps. Do not use for a single polyp (adenoma) or for a de novo (frank)

malignancy and a malignancy in a single polyp.

Note 2: Use this rule ONLY for adenocarcinoma in FAP.

Note 3: The disease process, treatment, and prognosis for FAP is not as favorable as a single polyp with adenocarcinoma.

Colon Solid Tumor Rules

September 2021 Update

Colon, Rectosigmoid, and Rectum Histology Rules

C180-C189, C199, C209

(Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140)

Jump to Equivalent Terms and Definitions

Jump to Multiple Primary Rules

Rule H13 Code adenocarcinoma in multiple adenomatous polyps 8221 when FAP is not mentioned AND

• There are at least 2 polyps with adenocarcinoma /2 or /3 AND

ο Less than or equal to 100 polyps are identified OR

ο The exact number of polyps is unknown/not documented

Note 1: Do not use this code for a malignancy in a single polyp (adenoma) or for a de novo (frank) malignancy.

Note 2: Use this rule ONLY for adenocarcinoma NOS in multiple polyps.

Rule H14 Code the histology of the invasive tumor when there are in situ /2 and invasive /3 tumors.

• One tumor is in situ and the other is invasive

• All tumors are a mixture of in situ and invasive histology

Rule H15 Code the histology when only one histology is present in all tumors.

Note 1: Use Table 1 to code histology. New codes, terms, and synonyms are included in Table 1 and coding errors may occur if

the table is not used.

Note 2: When the histology is not listed in Table 1, use the ICD-O and all updates.

Note 3: Submit a question to Ask a SEER Registrar

when the histology code is not found in Table 1, ICD-O or all updates.

Rule H16 Code the subtype/variant when the diagnosis is a NOS and a single subtype/variant of that NOS such as the following:

• Adenocarcinoma 8140 and a subtype/variant of adenocarcinoma

• Mixed adenoneuroendocrine carcinoma 8244 and a subtype/variant of mixed adenoneuroendocrine carcinoma

• Neuroendocrine carcinoma 8246 and a subtype/variant of neuroendocrine carcinoma

• Neuroendocrine tumor Grade 1 (G1) 8240 and a subtype/variant of neuroendocrine tumor Grade 1 (G1)

• Sarcoma 8800 and a subtype/variant of sarcoma

Note 1: All tumors may be mixed histologies (NOS and a subtype/variant of that NOS) OR one tumor may be a NOS histology

and the other tumor a subtype/variant of that NOS.

Note 2: See Table 1

in the Equivalent Terms and Definitions to find NOS and subtypes/variants.

Note 3: Check the Multiple Primary Rules to confirm that the tumors are a single primary.

Note 4: Only code subtypes/variant when pathology gives an exact diagnosis. Do not code the subtype/variant when modified by

terms such as differentiation, features of, etc., unless there is a specific code for the histology term with the modifier.

This is the end of instructions for Multiple Tumors Abstracted as a Single Primary.

Code the histology using the rule that fits the case.

Colon Solid Tumor Rules

September 2021 Update